NUCLEOSIDE-MODIFIED MRNA VACCINES PROTECT IFNAR -/- MICE AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS INFECTION

被引：0
|
作者：
Mirazimi, A. [1 ]
机构：
[1] Karolinska Inst, LABMED, Stockholm, Sweden
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2023年 / 130卷
关键词：
D O I：
10.1016/j.ijid.2023.04.030
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [1] Nucleoside-Modified mRNA Vaccines Protect IFNAR-/- Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
    Appelberg, Sofia
    John, Lijo
    Pardi, Norbert
    Vegvari, Akos
    Bereczky, Sandor
    Ahlen, Gustaf
    Monteil, Vanessa
    Abdurahman, Samir
    Mikaeloff, Flora
    Beattie, Mitchell
    Tam, Ying
    Sallberg, Matti
    Neogi, Ujjwal
    Weissman, Drew
    Mirazimi, Ali
    JOURNAL OF VIROLOGY, 2022, 96 (03)
  • [2] Crimean-Congo hemorrhagic fever virus
    Flick, R
    Whitehouse, CA
    CURRENT MOLECULAR MEDICINE, 2005, 5 (08) : 753 - 760
  • [3] Single dose, dual antigen RNA vaccines protect against lethal Crimean-Congo haemorrhagic fever virus infection in mice
    Leventhal, Shanna S.
    Meade-White, Kimberly
    Shaia, Carl
    Tipih, Thomas
    Lewis, Mathew
    Mihalakakos, Evan A.
    Hinkley, Troy
    Khandhar, Amit P.
    Erasmus, Jesse H.
    Feldmann, Heinz
    Hawman, David W.
    EBIOMEDICINE, 2024, 101
  • [4] Viral replicon particles protect IFNAR-/- mice against lethal Crimean-Congo hemorrhagic fever virus challenge three days after vaccination
    Spengler, Jessica R.
    Welch, Stephen R.
    Scholte, Florine E. M.
    Rodriguez, Sergio E.
    Harmon, Jessica R.
    Coleman-McCray, Joann D.
    Nichol, Stuart T.
    Montgomery, Joel M.
    Bergeron, Eric
    Spiropoulou, Christina F.
    ANTIVIRAL RESEARCH, 2021, 191
  • [5] Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus
    Garrison, Aura R.
    Moresco, Vanessa
    Zeng, Xiankun
    Cline, Curtis R.
    Ward, Michael D.
    Ricks, Keersten M.
    Olschner, Scott P.
    Cazares, Lisa H.
    Karaaslan, Elif
    Fitzpatrick, Collin J.
    Bergeron, Eric
    Pegan, Scott D.
    Golden, Joseph W.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [6] Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus
    Aura R. Garrison
    Vanessa Moresco
    Xiankun Zeng
    Curtis R. Cline
    Michael D. Ward
    Keersten M. Ricks
    Scott P. Olschner
    Lisa H. Cazares
    Elif Karaaslan
    Collin J. Fitzpatrick
    Éric Bergeron
    Scott D. Pegan
    Joseph W. Golden
    Nature Communications, 15
  • [7] Evaluation of Crimean-Congo Hemorrhagic Fever Virus Infection in Children
    Kizilgun, Murat
    Ozkaya-Parlakay, Aslinur
    Tezer, Hasan
    Gulhan, Belgin
    Yuksek, Saliha Kanik
    Celikel, Elif
    Tunc, Bahattin
    VECTOR-BORNE AND ZOONOTIC DISEASES, 2013, 13 (11) : 804 - 806
  • [8] Cytokine response in crimean-congo hemorrhagic fever virus infection
    Ergonul, Onder
    Seref, Ceren
    Eren, Sebnem
    Celikbas, Aysel
    Baykam, Nurcan
    Dokuzoguz, Basak
    Gonen, Mehmet
    Can, Fusun
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (10) : 1707 - 1713
  • [9] Development of vaccines against Crimean-Congo haemorrhagic fever virus
    Dowall, Stuart D.
    Carroll, Miles W.
    Hewson, Roger
    VACCINE, 2017, 35 (44) : 6015 - 6023
  • [10] GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection
    Golden, Joseph W.
    Shoemaker, Charles J.
    Lindquist, Michael E.
    Zeng, Xiankun
    Daye, Sharon P.
    Williams, Janice A.
    Liu, Jun
    Coffin, Kayla M.
    Olschner, Scott
    Flusin, Olivier
    Altamura, Louis A.
    Kuehl, Kathleen A.
    Fitzpatrick, Collin J.
    Schmaljohn, Connie S.
    Garrison, Aura R.
    SCIENCE ADVANCES, 2019, 5 (07):
12345